OUR STORY

 

PharmaSights all started with one simple question: "What if there was a better way?". Our founder, Alex Bonebakker, started asking this question after becoming increasingly frustrated with how hard it was to serve his life sciences clients. He was regularly hired as a consultant to help set their commercial strategy, only to face one obstacle after another.
 
An opaque data landscape made it almost impossible to understand which data providers offered what. Complicated TPAs and other procurement barriers meant extracting data was excruciatingly slow. And once obtained, data was fragmented and often riddled with mistakes, necessitating weeks of cleaning. What should have been weeks turned into months.

​

There had to be a better way.

​

In 2023, Alex sought to solve these problems by founding PharmaSights. He began experimenting with AI and with his team, developed proprietary IP that enables us to create AI-enhanced unique datasets at an unprecedented scale, generating millions of high-quality, proprietary data points in just days. These datasets go beyond what’s available on public platforms, offering a richer, more tailored view of the biopharma landscape. With LLM-powered data synthesis, we transform this vast data into cutting-edge insights, revealing trends and opportunities that would otherwise remain hidden.